Falciparum malaria, imported into The Netherlands, 1979-1988. II. Clinical features

Area of Science:

• Tropical Medicine
• Infectious Diseases
• Clinical Pharmacology

Background:

• Falciparum malaria remains a significant global health concern.
• Understanding the clinical presentation and impact of chemoprophylaxis is crucial for patient management.
• Chloroquine resistance necessitates ongoing evaluation of prophylactic efficacy.

Purpose of the Study:

• To investigate the clinical features of falciparum malaria in non-immune patients.
• To assess the influence of chloroquine chemoprophylaxis on these clinical features.
• To provide evidence for the protective effect of chloroquine, even against resistant strains.

Main Methods:

• Prospective study of 361 non-immune patients with falciparum malaria (1979-1988).
• Analysis of clinical data based on claimed compliance with malaria prophylaxis.
• Comparison of outcomes between patients who took prophylaxis, those who did not, and those infected with chloroquine-resistant strains.

Main Results:

• Patients adhering to chloroquine prophylaxis experienced milder illness, lower parasitemia, and fewer complications.
• A protective effect of chloroquine was evident when comparing non-prophylaxis users with those infected by chloroquine-resistant strains.
• Overall complication rate was 14%, with pregnant women at higher risk; case-fatality rate was 0.3%.

Conclusions:

• Chloroquine prophylaxis can still offer a protective effect against falciparum malaria, modulating clinical features.
• The degree of chloroquine resistance influences the protective efficacy of prophylaxis.
• Further research is needed to fully understand the modulating effects of chloroquine prophylaxis in malaria treatment.